Aldeyra Therapeutics (ALDX)
(Delayed Data from NSDQ)
$3.94 USD
0.00 (0.00%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $3.94 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -0.08 |
EPS Last Quarter | -0.08 |
Last EPS Surprise | 61.90% |
ABR | 1.00 |
Earnings ESP
|
-12.50% |
---|---|
Current Year | -0.14 |
Next Year | -0.43 |
EPS (TTM) | -0.64 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 6.00M | NA | 100.00M | 35.61M |
# of Estimates | 1 | NA | 1 | 3 |
High Estimate | 6.00M | NA | 100.00M | 67.30M |
Low Estimate | 6.00M | NA | 100.00M | 18.70M |
Year ago Sales | 0.00M | 0.00M | NA | 100.00M |
Year over Year Growth Est. | NA | NA | NA | -64.39% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.08 | -0.12 | -0.14 | -0.43 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | -0.15 | -0.17 | -0.72 | -0.63 |
High Estimate | 0.02 | -0.10 | 1.15 | 0.55 |
Low Estimate | -0.15 | -0.17 | -0.72 | -0.85 |
Year ago EPS | -0.27 | -0.15 | -0.64 | -0.14 |
Year over Year Growth Est. | 70.37% | 20.00% | 78.13% | -208.93% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 0 | 0 | 4 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.08 | -0.12 | -0.14 | -0.43 |
7 Days Ago | -0.08 | -0.12 | -0.14 | -0.43 |
30 Days Ago | -0.08 | -0.13 | -0.26 | -0.43 |
60 Days Ago | NA | NA | -0.45 | -0.57 |
90 Days Ago | NA | NA | -1.08 | -0.60 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.09 | -0.10 | -0.47 | -0.43 |
Zacks Consensus Estimate | -0.08 | -0.12 | -0.14 | -0.43 |
Earnings ESP | -12.50% | 16.67% | -235.71% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.08 | -0.14 | -0.15 | -0.27 | NA |
Estimate | -0.21 | NA | -0.31 | -0.30 | NA |
Difference | 0.13 | NA | 0.16 | 0.03 | 0.11 |
Surprise | 61.90% | NA | 51.61% | 10.00% | 41.17% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more